Publication Topic

Scott LLF, Harris MA, Unice KM, Scott P, Nguyen LM, Haws LC, Paustenbach D. 2008. Addendum to: Evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001-2002 National Health and Nutrition Examination Survey of the United States population. J Exp Sci Env Epidemiol 18(5):524-532; doi: 10.1038/jes.2008.10.

Urban JD, Haws LC, Staskal DF, Scott LF, Scott PS, Tachovsky AT, Unice KM, Harris MA. A framework for evaluating serum dioxin data derived from biomonitoring studies. Presented at Dioxin 2008, Birmingham, England, August 17-22 2008.

Ferriby LL, Knutsen JS, Harris MA, Unice KM, Scott P, Nony P, Haws LC, Paustenbach D. 2007. Evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001-2002 National Health and Nutrition Examination Survey of the United States Population. J Exp Sci Environ Epidemiol 17(4):358-371; doi: 10.1038/sj.jes.7500498.

Ferriby LL, Harris MA, Unice KM, Scott PK, Haws LC, Paustenbach DJ. 2007. Development of PCDD/F and dioxin-like PCB serum concentration reference values for the general U.S. population using the 2006 WHO TEFs and the 2001-2002 NHANES data. Society of Toxicology 46th Annual Meeting, Charlotte, NC, March 2007.

Haws LC, Scott LLF, Staskal DF, Harris MA, Finley BL. Dioxin-like compounds in workers at a primary magnesium production facility. Dioxin 2007, Tokyo, Japan, 2007.

Haws LC, Scott LLF, Staskal D, Harris M, Finley B. Evaluation of biomonitoring data for dioxin-like compounds in workers at a primary magnesium production facility. Society for Risk Analysis Annual Meeting, San Antonio, TX, 2007.

Haws LC, Walker NJ, DeVito MJ, Birnbaum LS, Unice KM, Scott PK, Harris MA, Farland WH, Finley BL, Staskal DF. Development of weighted distributions of REPs for dioxin-like compounds (DLCs). Society of Toxicology 46th Annual Meeting, Charlotte, NC, 2007.

Scott LLF, Harris M, Unice KM, Scott P, Nguyen LM, Haws LC, Paustenbach D. 2007. Effects of excluding serum PCDD/F and dioxin-like PCB data of individuals with incomplete congener profiles on estimates of total TEQ. Ann Epidemiol 17(9):732; 10.1016/j.annepidem.2007.07.032.

Scott P, Haws LC, Scott L, Harris M. 2007. Evaluation of background dioxin-like PCB congener profiles in human serum collected during NHANES 2001-2002 using principal components analysis. Dioxin 2007, September 2-7, 2007. Tokyo, Japan.

Ferriby LL, Williams ES, Lukesemburg WJ, Paustenbach DJ, Haws LC, Birnbaum LS, Harris M. Comparing PCDDs, PCDFs, and dioxin-like PCBs in farm-raised and wild-caught catfish from Southern Mississippi. Dioxin 2006, Oslo, Norway, August 2006.

Ferriby LL, Franke K, Unice KM, Scott P, Haws LC, Harris M, Paustenbach DJ. 2006. Serum reference levels of PCDD/Fs and dioxin-like PCBs stratified by race/ethnicity, gender and age for the general U.S. population. American Public Health Association Annual Meeting and Exposition. November 4-8, 2006. Boston, MA.

Haws L. The use of toxic equivalency factors to assess potential human health risks posed by dioxin-like compounds: Keeping up with the science. Presented at Michigan State University, Toxicology Program Seminar Series, September,, 2006.

Van den Berg M, Birnbaum L, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws LC, Rose M, Safe S, Schrenk D, Tohyama C, Tritscher A, Tuomisto J, Tysklind M, Walke Nr, Peterson RE. 2006. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93(2):223-241; doi: 10.1093/toxsci/kfl055.

Haws LC, Scott PK, Unice KM, Gough M, Harris MA, Staskal DF, Paustenbach DJ, Pavuk M. Are dioxin body burdens surrogates for other risk factors in associations between dioxin and diabetes? Dioxin 2006, Oslo, Norway, August 2006.

Haws LC, DeVito MJ, Birnbaum LS, Walker NJ, Scott PK, Unice KM, Harris MA, Farland WH, Finley BL, Staskal DF. An alternative method for establishing TEFs for dioxin-like compounds. Part 2. Development of an approach to quantitatively weight the underlying potency data. Dioxin 2006, Oslo, Norway, 2006.

Paustenbach DJ, Harris M, Ferriby LL, Williams ES, Haws LC, Unice KM, Scott PK. Development of PCDD/F TEQ serum reference values for the U.S. population for use in evaluating biomonitoring results. Dioxin 2006, Oslo, Norway, August 2006.

Van den Berg M, Birnbaum L, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws LC, et al. Human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds: The WHO 2005 re-evaluation. Dioxin 2006, Oslo, Norway, August 2006.

Connor K, Harris M, Edwards M, Chu A, Clark G, Finley B. Estimating the total TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study. Dioxin 2005, Toronto, Canada, 2005.

Harris M, Finley B. The TCDD TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study. Society of Toxicology 44th Annual Meeting, New Orleans, LA, 2005.

Harris M, Finley B, Scott P. Development of a relative estimate of potency distribution for 2,3,7,8-TCDF. Dioxin 2005, Toronto, Canada, 2005.